Comment from PCOS Challenge: The National Polycystic Ovary Syndrome Association

Summary: PCOS Challenge, a patient advocacy organization, supports the FDA's Patient-Focused Drug Development (PFDD) meetings. They argue that these meetings create durable structural changes by organizing patient communities, identifying critical research gaps, and providing a reusable evidence base for developers and clinicians to align drug development with patient-defined priorities.